共 12 条
[1]
Quesada J.R., Talpaz M., Rios A., Kurzrock R., Gutterman J., Clinical toxicity of interferons in cancer patients: a review, J Clin Oncol, 4, pp. 234-243, (1986)
[2]
Fentiman J.S., Thomas B.S., Balkwill F.R., Rubens R.D., Hayward J.L., Primary hypothyroidism associated with interferon therapy of breast cancer, Lancet, 1, (1985)
[3]
Akard L.P., Hoffman R., Elias L., Saiers J.H., Alpha-interferon and immune hemolytic anemia, Ann Intern Med, 105, (1986)
[4]
Abdi E.A., Venner P.M., Immune thrombocytopenia after alpha-interferon therapy in patients with cancer, JAMA, 255, pp. 1878-1879, (1986)
[5]
Mangan K.F., Zidar B., Shadduck R.K., Zeigler Z., Winkelstein A., Interferon-induced aplasia: Evidence for T-cell mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin, Am J Hematol, 19, pp. 401-413, (1985)
[6]
Conlon K.C., Urba W.J., Smith J.W., Steis R.G., Longo D.L., Clark J.W., Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy, Cancer, 65, pp. 2237-2242, (1990)
[7]
Schilling P.J., Kurzrock R., Kantarjian H., Gutterman J.U., Talpaz M., Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia, Cancer, 68, pp. 1536-1537, (1991)
[8]
Ronnblom L.E., Gunnar V.A., Kjell E.O., Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors, Annals of Internal Medicine, 115, pp. 178-183, (1991)
[9]
Chazerain P., Meyer O., Kahn M.F., Rheumatoid arthritis-like disease after alpha-interferon therapy, Ann Intern Med, 116, (1992)
[10]
Ueno Y., Sohma T., Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma, Ann Intern Med, 117, pp. 266-267, (1992)